BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25448680)

  • 1. Mode of substrate recognition by the Josephin domain of ataxin-3, which has an endo-type deubiquitinase activity.
    Satoh T; Sumiyoshi A; Yagi-Utsumi M; Sakata E; Sasakawa H; Kurimoto E; Yamaguchi Y; Li W; Joazeiro CA; Hirokawa T; Kato K
    FEBS Lett; 2014 Nov; 588(23):4422-30. PubMed ID: 25448680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the role of the Josephin domain in the PolyUb binding and cleavage properties of ataxin-3.
    Nicastro G; Todi SV; Karaca E; Bonvin AM; Paulson HL; Pastore A
    PLoS One; 2010 Aug; 5(8):e12430. PubMed ID: 20865150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Josephin domain of ataxin-3 contains two distinct ubiquitin-binding sites.
    Nicastro G; Masino L; Esposito V; Menon RP; De Simone A; Fraternali F; Pastore A
    Biopolymers; 2009 Dec; 91(12):1203-14. PubMed ID: 19382171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of a Josephin-ubiquitin complex: evolutionary restraints on ataxin-3 deubiquitinating activity.
    Weeks SD; Grasty KC; Hernandez-Cuebas L; Loll PJ
    J Biol Chem; 2011 Feb; 286(6):4555-65. PubMed ID: 21118805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deubiquitinating function of ataxin-3: insights from the solution structure of the Josephin domain.
    Mao Y; Senic-Matuglia F; Di Fiore PP; Polo S; Hodsdon ME; De Camilli P
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12700-5. PubMed ID: 16118278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flanking domain stability modulates the aggregation kinetics of a polyglutamine disease protein.
    Saunders HM; Gilis D; Rooman M; Dehouck Y; Robertson AL; Bottomley SP
    Protein Sci; 2011 Oct; 20(10):1675-81. PubMed ID: 21780213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional interactions as a survival strategy against abnormal aggregation.
    Masino L; Nicastro G; Calder L; Vendruscolo M; Pastore A
    FASEB J; 2011 Jan; 25(1):45-54. PubMed ID: 20810784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NEDD8: a new ataxin-3 interactor.
    Ferro A; Carvalho AL; Teixeira-Castro A; Almeida C; Tomé RJ; Cortes L; Rodrigues AJ; Logarinho E; Sequeiros J; Macedo-Ribeiro S; Maciel P
    Biochim Biophys Acta; 2007 Nov; 1773(11):1619-27. PubMed ID: 17935801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and functional analysis of the Josephin domain of the polyglutamine protein ataxin-3.
    Chow MK; Mackay JP; Whisstock JC; Scanlon MJ; Bottomley SP
    Biochem Biophys Res Commun; 2004 Sep; 322(2):387-94. PubMed ID: 15325242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3.
    Masino L; Nicastro G; Menon RP; Dal Piaz F; Calder L; Pastore A
    J Mol Biol; 2004 Dec; 344(4):1021-35. PubMed ID: 15544810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Josephin domain determines the morphological and mechanical properties of ataxin-3 fibrils.
    Masino L; Nicastro G; De Simone A; Calder L; Molloy J; Pastore A
    Biophys J; 2011 Apr; 100(8):2033-42. PubMed ID: 21504740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The solution structure of the Josephin domain of ataxin-3: structural determinants for molecular recognition.
    Nicastro G; Menon RP; Masino L; Knowles PP; McDonald NQ; Pastore A
    Proc Natl Acad Sci U S A; 2005 Jul; 102(30):10493-8. PubMed ID: 16020535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Josephin domain-containing proteins from a variety of species are active de-ubiquitination enzymes.
    Tzvetkov N; Breuer P
    Biol Chem; 2007 Sep; 388(9):973-8. PubMed ID: 17696782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure validation of the Josephin domain of ataxin-3: conclusive evidence for an open conformation.
    Nicastro G; Habeck M; Masino L; Svergun DI; Pastore A
    J Biomol NMR; 2006 Dec; 36(4):267-77. PubMed ID: 17096206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional analysis of ataxin-2 and ataxin-3.
    Albrecht M; Golatta M; Wüllner U; Lengauer T
    Eur J Biochem; 2004 Aug; 271(15):3155-70. PubMed ID: 15265035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of ataxin-3 with huntingtin-associated protein 1 through Josephin domain.
    Takeshita Y; Fujinaga R; Kokubu K; Islam MN; Jahan MR; Yanai A; Kakizuka A; Shinoda K
    Neuroreport; 2011 Mar; 22(5):232-8. PubMed ID: 21386698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteotoxic stress increases nuclear localization of ataxin-3.
    Reina CP; Zhong X; Pittman RN
    Hum Mol Genet; 2010 Jan; 19(2):235-49. PubMed ID: 19843543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ataxin-3 is a multivalent ligand for the parkin Ubl domain.
    Bai JJ; Safadi SS; Mercier P; Barber KR; Shaw GS
    Biochemistry; 2013 Oct; 52(42):7369-76. PubMed ID: 24063750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys63 linkages in mixed linkage ubiquitin chains.
    Winborn BJ; Travis SM; Todi SV; Scaglione KM; Xu P; Williams AJ; Cohen RE; Peng J; Paulson HL
    J Biol Chem; 2008 Sep; 283(39):26436-43. PubMed ID: 18599482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly-ubiquitin binding by the polyglutamine disease protein ataxin-3 links its normal function to protein surveillance pathways.
    Chai Y; Berke SS; Cohen RE; Paulson HL
    J Biol Chem; 2004 Jan; 279(5):3605-11. PubMed ID: 14602712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.